NCT06023797已完成不适用
Retrospective Research on Lung Cancer Patients Receiving Neoadjuvant Immunochemotherapy From Zhongshan Hospital Fudan University.
Shanghai Zhongshan Hospital1 个研究点 分布在 1 个国家目标入组 83 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 83
- 试验地点
- 1
- 主要终点
- Overall survival (OS)
研究概览
简要总结
We retrospectively analyzed lung cancer patients who had NAICT and surgery in the Department of Thoracic Surgery, Zhongshan Hospital. NAICT was defined as chemotherapy that included at one application of PD-1 inhibitor.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Lung surgery was performed in the Department of Thoracic Surgery at Zhongshan Hospital;
- •At least one cycle of neoadjuvant treatment containing the immune drug PD-1 immunosuppressant was performed before surgery;
- •Malignancy was present and confirmed in the pathology before treatment and after surgery;
- •The lung lesion was the primary lesion.
排除标准
- •No lung surgery was performed until 2022.11;
- •No preoperative neoadjuvant therapy was performed or recorded;
- •Neoadjuvant therapy did not include immune drugs;
- •Previous history of malignancy (including surgery and adjuvant therapy);
- •Previous use of system-related immune medicines, such as immunosuppressants and monoclonal antibodies; and
- •Other conditions inappropriate for enrollment by the investigator.
研究组 & 干预措施
MAICT
chemotherapy that included at one application of PD-1 inhibitor
干预措施: Neoadjuvant immunochemotherapy (Drug)
结局指标
主要结局
Overall survival (OS)
时间窗: 2017-2023
Overall defined as the living status, alive or dead
Progression-free survival (PFS)
时间窗: 2017-2023
Progression-free defined as status of recurrence of lung cancer
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine KinaseNon-Small-Cell Lung CancerNCT02755337Dr. Soetomo General Hospital70
已完成
不适用
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line TreatmentsNon-small Cell Lung Cancer (NSCLC)NCT06617390Daiichi Sankyo1,041
已完成
Unknown
A retrospective analysis on the lung cancer specimens for Oncomine Dx Target Test in Keio University Hospitalon-small cell lung cancer (NSCLC)JPRN-UMIN000050424Keio University School of Medicine500
已完成
不适用
Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in BrazilCarcinoma, Non-Small-Cell LungNCT04947683Latin American Cooperative Oncology Group101
已完成
不适用
Follow up after curative-intent lung cancer treatmenton-small cell lung cancerNon-small cell lung cancerCancerISRCTN16281786Clinic of Pulmonary and Sleep Medicine96